Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Ressel

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Oncotarget|February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Veterinary Pathology|September 20, 2018
Observational Study Design in Veterinary Pathology, Part 2: MethodologyJeff L Caswell, Laura L Bassel, Jamie L Rothenburger, et al.
Veterinary Pathology|August 4, 2018
Observational Study Design in Veterinary Pathology, Part 1: Study DesignJeff L Caswell, Laura L Bassel, Jamie L Rothenburger, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Oncotarget|February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Veterinary Pathology|September 20, 2018
Observational Study Design in Veterinary Pathology, Part 2: MethodologyJeff L Caswell, Laura L Bassel, Jamie L Rothenburger, et al.
Veterinary Pathology|August 4, 2018
Observational Study Design in Veterinary Pathology, Part 1: Study DesignJeff L Caswell, Laura L Bassel, Jamie L Rothenburger, et al.
Pageof 8